Diacylglycerol Metabolism and Signaling Is a Driving Force Underlying FASN Inhibitor Sensitivity in Cancer Cells

Document Details

Document Type
Pub Defense Publication
Publication Date
Apr 17, 2015
Source ID
10.1021/acschembio.5b00240

Entities

People

  • Daniel I. Benjamin
  • Daniel Nomura
  • Daniel S. Li
  • George Kemble
  • Timothy Heuer
  • Wallace Lowe

Organizations

  • American Cancer Society
  • Kinship Conservation Fellows
  • National Cancer Institute
  • United States Department of Defense